These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34503113)

  • 21. Stereotactic body radiotherapy or stereotactic ablative radiotherapy versus surgery for patients with T1-3N0M0 non-small cell lung cancer: a systematic review and meta-analysis.
    Li M; Yang X; Chen Y; Yang X; Dai X; Sun F; Zhang L; Zhan C; Feng M; Wang Q
    Onco Targets Ther; 2017; 10():2885-2892. PubMed ID: 28652770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study Protocol STEREOLAB: Stereotactic Liver Ablation Assisted with Intra-Arterial CT Hepatic Arteriography and Ablation Confirmation Software Assessment.
    Paolucci I; Albuquerque Marques Silva J; Lin YM; Fellman BM; Jones KA; Tatsui CE; Weinberg JS; Ruiz J; Tan J; Brock KK; Bale R; Odisio BC
    Cardiovasc Intervent Radiol; 2023 Dec; 46(12):1748-1754. PubMed ID: 37563313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiofrequency ablation in the treatment of liver metastases from colorectal cancer.
    Cirocchi R; Trastulli S; Boselli C; Montedori A; Cavaliere D; Parisi A; Noya G; Abraha I
    Cochrane Database Syst Rev; 2012 Jun; (6):CD006317. PubMed ID: 22696357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is radiofrequency ablation more effective than stereotactic ablative radiotherapy in patients with early stage medically inoperable non-small cell lung cancer?
    Bilal H; Mahmood S; Rajashanker B; Shah R
    Interact Cardiovasc Thorac Surg; 2012 Aug; 15(2):258-65. PubMed ID: 22581864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Added Diagnostic Value of Transcatheter CT Hepatic Arteriography for Intraprocedural Detection of Previously Unknown Colorectal Liver Metastases During Percutaneous Ablation and Impact on the Definitive Treatment Plan.
    van der Lei S; Opperman J; Dijkstra M; Kors N; Boon R; van den Bemd BAT; Timmer FEF; Nota IMGC; van den Bergh JE; de Vries JJJ; Scheffer HJ; Geboers B; Neuss T; Schouten E; Lissenberg-Witte BI; Puijk RS; Meijerink MR
    Cardiovasc Intervent Radiol; 2023 Sep; 46(9):1257-1266. PubMed ID: 37491521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant Chemotherapy Followed by Radiofrequency Ablation Prolongs Survival for Ablatable Colorectal Liver Metastasis: A Propensity Score Matching Comparative Study.
    Chen Y; Xu Y; Xu L; Han F; Huang Y; Jiang H; Wu J; Zhang Y
    Front Oncol; 2021; 11():758552. PubMed ID: 34745996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MWA Versus RFA for Perivascular and Peribiliary CRLM: A Retrospective Patient- and Lesion-Based Analysis of Two Historical Cohorts.
    van Tilborg AA; Scheffer HJ; de Jong MC; Vroomen LG; Nielsen K; van Kuijk C; van den Tol PM; Meijerink MR
    Cardiovasc Intervent Radiol; 2016 Oct; 39(10):1438-46. PubMed ID: 27387188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial.
    Ball D; Mai GT; Vinod S; Babington S; Ruben J; Kron T; Chesson B; Herschtal A; Vanevski M; Rezo A; Elder C; Skala M; Wirth A; Wheeler G; Lim A; Shaw M; Schofield P; Irving L; Solomon B;
    Lancet Oncol; 2019 Apr; 20(4):494-503. PubMed ID: 30770291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiofrequency versus microwave ablation for intraoperative treatment of colorectal liver metastases.
    Krul MF; Gerritsen SL; Vissers FL; Klompenhouwer EG; Ruers TJ; Kuhlmann KF; Kok NF
    Eur J Surg Oncol; 2022 Apr; 48(4):834-840. PubMed ID: 34686404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic Ablative Radiation Therapy for Colorectal Liver Metastases.
    McDermott RL; Dunne EM; Zhao Y; Bergman A; Liu MC; Schellenberg D; Ma RM
    Clin Colorectal Cancer; 2023 Mar; 22(1):120-128. PubMed ID: 36526537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes after resection and/or radiofrequency ablation for recurrence after treatment of colorectal liver metastases.
    Hof J; Wertenbroek MW; Peeters PM; Widder J; Sieders E; de Jong KP
    Br J Surg; 2016 Jul; 103(8):1055-62. PubMed ID: 27193207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of radiofrequency ablation and ablative external radiotherapy for the treatment of intrahepatic malignancies: A hybrid meta-analysis.
    Rim CH; Lee JS; Kim SY; Seong J
    JHEP Rep; 2023 Jan; 5(1):100594. PubMed ID: 36561128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereotactic Ablative Radiation Therapy (SABR) for Adolescent and Young Adult Malignancies.
    Singh R; Bishop S; Jenkins J; Davis J; Upadhyay R; McLaughlin C; Sharma S; Baliga S; Palmer JD
    Cureus; 2024 Aug; 16(8):e66890. PubMed ID: 39280449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery.
    Chang JY; Mehran RJ; Feng L; Verma V; Liao Z; Welsh JW; Lin SH; O'Reilly MS; Jeter MD; Balter PA; McRae SE; Berry D; Heymach JV; Roth JA;
    Lancet Oncol; 2021 Oct; 22(10):1448-1457. PubMed ID: 34529930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer.
    Brooks ED; Sun B; Feng L; Verma V; Zhao L; Gomez DR; Liao Z; Jeter M; O'Reilly M; Welsh JW; Nguyen QN; Erasmus JJ; Eapen G; Ahrar K; Antonoff MB; Hahn SM; Heymach JV; Rice DC; Chang JY
    JAMA Netw Open; 2018 Aug; 1(4):e181390. PubMed ID: 30646121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognosis of radiofrequency ablation versus hepatic resection for patients with colorectal liver metastases: A systematic review and meta-analysis based on 22 studies.
    Yang G; Wang G; Sun J; Xiong Y; Li W; Tang T; Li J
    Int J Surg; 2021 Mar; 87():105896. PubMed ID: 33588125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Single-Center Retrospective Analysis of Periprocedural Variables Affecting Local Tumor Progression after Radiofrequency Ablation of Colorectal Cancer Liver Metastases.
    Han K; Kim JH; Yang SG; Park SH; Choi HK; Chun SY; Kim PN; Park J; Lee M
    Radiology; 2021 Jan; 298(1):212-218. PubMed ID: 33170105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Total tumor volume as a predictor of survival in patients with multiple oligometastases treated with stereotactic ablative radiotherapy (SABR).
    Franzese C; Vernier V; Franceschini D; Comito T; Navarria P; Clerici E; Teriaca MA; Massaro M; Di Cristina L; Marini B; Galdieri C; Mancosu P; Tomatis S; Scorsetti M
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10495-10503. PubMed ID: 37280407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment outcomes of stereotactic ablative body radiotherapy on oligometastases from colorectal cancer: early results of a single institution service evaluation.
    Duong J; Stewart-Lord A; Nariyangadu P; Harrison M; Tsang YM
    BJR Open; 2022; 4(1):20210071. PubMed ID: 36105422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival of patients with non-resectable, chemotherapy-resistant colorectal cancer liver metastases undergoing conventional lipiodol-based transarterial chemoembolization (cTACE) palliatively versus neoadjuvantly prior to percutaneous thermal ablation.
    Vogl TJ; Lahrsow M; Albrecht MH; Hammerstingl R; Thompson ZM; Gruber-Rouh T
    Eur J Radiol; 2018 May; 102():138-145. PubMed ID: 29685527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.